| 1 day | -1.13% |
| Manager | Title | Age | Since |
|---|---|---|---|
Evan Loh
CEO | Chief Executive Officer | 67 | 2025-05-20 |
| Chief Tech/Sci/R&D Officer | - | 2019-12-31 | |
Jonathan Neely
IRC | Investor Relations Contact | - | 2020-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Evan Loh
BRD | Director/Board Member | 67 | 2025-05-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/21/25 | Issuer sale | Chief Financial Officer | 82,491 | 0.8204% | ||
| 5/21/25 | Issuer sale | Director | 12,624 | 0.1255% | ||
| 5/21/25 | Issuer sale | Director | 12,624 | 0.1255% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.13% | +1.91% | - | - | 97.22M | ||
| -2.29% | -5.34% | +28.73% | +128.34% | 1,204B | ||
| -2.04% | -5.78% | +31.91% | +78.34% | 643B | ||
| -0.86% | -3.71% | +21.74% | +105.02% | 501B | ||
| -1.04% | -1.80% | +28.69% | +68.01% | 378B | ||
| -3.61% | -9.62% | +39.73% | +30.53% | 327B | ||
| -3.22% | -5.20% | +24.48% | +51.30% | 285B | ||
| -2.51% | -4.49% | -2.15% | +29.67% | 270B | ||
| -1.14% | -6.05% | +28.16% | +65.35% | 237B | ||
| -1.45% | -0.85% | +30.03% | +120.72% | 207B | ||
| Average | -1.93% | -4.40% | +25.70% | +75.25% | 450B | |
| Weighted average by Cap. | -2.03% | -4.71% | +26.93% | +87.91% |
Employees
128
Sector
Pharmaceuticals
















